Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087. Issue 2 (December 2015)

Record Type:
Journal Article
Title:
Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087. Issue 2 (December 2015)
Main Title:
Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087
Authors:
Chen, Robert
Armand, Phillippe
Fanale, Michelle
Ribrag, Vincent
Zinzani, Pier
Ricart, Alejandro
Thompson, Seth
Balakumaran, Arun
Molin, Daniel
Shipp, Margaret
Moskowitz, Craig
Abstract:
Is Part Of:
Journal for immunotherapy of cancer. Volume 3:Issue 2(2015)
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Issue Display:
Volume 3, Issue 2 (2015)
Year:
2015
Volume:
3
Issue:
2
Issue Sort Value:
2015-0003-0002-0000
Page Start:
1
Page End:
2
Publication Date:
2015-12
Subjects:
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:
http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:
10.1186/2051-1426-3-S2-P146 ↗
Languages:
English
ISSNs:
2051-1426
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
10242.xml